- Abstract:
-
OBJECTIVE: While the lipido-sterolic extract of Serenoa repens (LSESr)-Permixon((R))-has been shown to have an equivalent efficacy to finasteride in patients with benign prostatic hyperplasia (BPH), to date, there has been no valid comparison of phytotherapy with alpha-blockers. The aim of this study was to assess the equivalent efficacy of Permixon and tamsulosin. METHODS: Eight hundred and eleven men with symptomatic BPH (I-PSS> or =10) were recruited in 11 European countries for a 12-m...
Expand abstract - Publication status:
- Published
- Journal:
- European urology
- Volume:
- 41
- Issue:
- 5
- Pages:
- 497-506
- Publication date:
- 2002-05-05
- DOI:
- EISSN:
-
1873-7560
- ISSN:
-
0302-2838
- URN:
-
uuid:082b4a89-8768-4843-8af2-15bc8218a162
- Source identifiers:
-
120662
- Local pid:
- pubs:120662
- Copyright date:
- 2002
Journal article
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record